Bionano Genomics (BNGO)

• Market cap: $19.9M
• 1 day: -2.74%
• 5 days: -19.72%
• 1 month: -6.88%
• 3 months: -51.91%
• 6 months: -75.77%
• Year to date: -90.25%
• 1 year: -87.96%
• 5 years: -98.11%
• 10 years: -99.72%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

About: Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Employees: 344

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

155% more call options, than puts

Call options by funds: $51K | Put options by funds: $20K

3.23% less ownership

Funds ownership: 9.61% [Q2] → 6.38% (-3.23%) [Q3]

10% less funds holding

Funds holding: 58 [Q2] → 52 (-6) [Q3]

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

33% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 18

45% less capital invested

Capital invested by funds: $4.5M [Q2] → $2.48M (-$2.02M) [Q3]